ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CLL Cello Health Plc

161.00
0.00 (0.00%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cello Health Plc LSE:CLL London Ordinary Share GB00B0310763 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 161.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Cello Health PLC Block listing Interim Review (6423A)

22/01/2020 4:40pm

UK Regulatory


Cello Health (LSE:CLL)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Cello Health Charts.

TIDMCLL

RNS Number : 6423A

Cello Health PLC

22 January 2020

22 January 2020

Cello Health plc

("Cello" or the "Company")

Block Listing Update

Total Voting Rights

The Company notifies that, since the date of its most recent block listing update, a total of 1,232,928 new ordinary shares of 10p each in the share capital of the Company have been issued and allotted (pursuant to the Company's PSP Option Scheme 2010, its Approved Share Option Plan 2009 and its Unapproved Scheme 2010) and admitted to trading in accordance with the block listing. An update in accordance with Schedule 6 of the AIM Rules for Companies is set out below.

As at today's date, Cello's issued share capital comprises 106,778,473 ordinary shares of 10 pence each ("Ordinary Shares"), of which 453,000 Ordinary Shares are held in treasury. The total number of current voting rights in the Company is therefore 106,325,473 Ordinary Shares, which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquires

 
 Cello Health                   020 7812 8460 
 Mark Scott, Chief Executive 
 Mark Bentley, Group Finance 
  Director 
 Cenkos Securities              020 7397 8900 
 Giles Balleny 
 Harry Hargreaves 
 Buchanan                       020 7466 5000 
 Mark Court 
 Jamie Hooper 
 Sophie Wills 
 

BLOCK LISTING SIX MONTHLY RETURN

 
 Name of applicant:                        Cello Health plc 
 Name of scheme:                           PSP Option Scheme 2010, Approved 
                                            Share Option Plan 2009 and Unapproved 
                                            Scheme 2010 
                                          ------------------------------------------- 
 Period of return:             From:       23 May 2019         To:     21 January 
                                                                        2020 
                              ----------  ------------------  ------  --------------- 
 Balance of unallotted securities 
  under scheme(s) from previous 
  return:                                  2,918,747 
                                          ------------------------------------------- 
 Plus: The amount by which the             - 
  block scheme(s) has been increased 
  since the date of the last 
  return (if any increase has 
  been applied for): 
                                          ------------------------------------------- 
 Less: Number of securities 
  issued/allotted under scheme(s) 
  during period (see LR3.5.7G):            (1,232,928) 
                                          ------------------------------------------- 
 Equals: Balance under scheme(s) 
  not yet issued/allotted at 
  end of period:                           1,685,819 
                                          ------------------------------------------- 
 Name of contact:                          Mark Bentley, Group Finance Director 
                                          ------------------------------------------- 
 Telephone number of contact:              020 7812 8460 
                                          ------------------------------------------- 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

BLRFLFVRLAIFFII

(END) Dow Jones Newswires

January 22, 2020 11:40 ET (16:40 GMT)

1 Year Cello Health Chart

1 Year Cello Health Chart

1 Month Cello Health Chart

1 Month Cello Health Chart

Your Recent History

Delayed Upgrade Clock